Product Information
PERSERIS ER 90 MG SYRINGE KIT is a brand product labeled by Indivior Inc., priced at $2081.2889 per EA under NDC 12496009001. Its NADAC has been published 220 times since Jul 20, 2022.
FDA first approved this application on Jul 27, 2018.
The High Outlier badge above means this manufacturer's average price in the Risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Indivior Inc.NDC
12496009001
Classification
Brand
Dosage Form
KIT
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA210655FDA Approved
7/27/2018
On Market Since
11/9/2018
Price Statistics
The NADAC for PERSERIS ER 90 MG SYRINGE KIT has been published 220 times since Jul 20, 2022, and over the history we have for it it has risen 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2081.2889 per EA |
|---|---|
| All-time high | $2086.2230 (Sep 16, 2026) |
| All-time low | $1879.8420 (Jul 20, 2022) |
| 52-week high | $2086.2230 |
| 52-week low | $2071.9830 |
| Median price | $2074.2770 |
| Average price | $2029.3252 |
| Largest weekly change | +5.0% (Jan 3, 2024) |
| Weeks tracked | 220 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Indivior Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Risperidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PERSERIS ER 90 MG SYRINGE KIT?
The current National Average Drug Acquisition Cost (NADAC) for PERSERIS ER 90 MG SYRINGE KIT, manufactured by Indivior Inc., is $2081.2889 per EA (NDC 12496009001), effective Sep 30, 2026.
How has the price of PERSERIS ER 90 MG SYRINGE KIT changed over time?
Over the history we have for it, the NADAC for PERSERIS ER 90 MG SYRINGE KIT has risen 10.7%. It has been tracked across 220 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for PERSERIS ER 90 MG SYRINGE KIT?
Since Jul 20, 2022, the NADAC for PERSERIS ER 90 MG SYRINGE KIT has ranged from a low of $1879.8420 (Jul 20, 2022) to a high of $2086.2230 (Sep 16, 2026), with a median of $2074.2770 per EA.
Are there cheaper alternatives to PERSERIS ER 90 MG SYRINGE KIT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RISPERIDONE ER 25 MG VIAL, is $355.2316 per EA — about 83% below PERSERIS ER 90 MG SYRINGE KIT.
Who manufactures PERSERIS ER 90 MG SYRINGE KIT?
PERSERIS ER 90 MG SYRINGE KIT (NDC 12496009001) is labeled by Indivior Inc., and CMS classifies it as a brand product.